Hope For The Best: New Medications May Slow The Progress of Alzheimer’s- If You Can Access Them
May 17, 2023
For the more than 6 million Americans currently thought to have Alzheimer’s, and their loved ones, the possible benefits of new medications can’t come soon enough. As the most common cause of dementia, Alzheimer’s Disease predominantly afflicts older women (⅔ of Alzheimer’s patients are female) and almost ¾ of those…
Happy Memories: Repairing and Improving Your Memory
April 19, 2023
The Scottish novelist and playwright (and creator of Peter Pan) J. M. Barrie once said, “God gave us memories that we might have roses in December.” Memory, and the memories we store, allow us to live in a world more robust and rewarding than we might otherwise be able to…
Books On Life: New Words Of Wisdom For The Journey of Aging
March 8, 2023
In addition to the sheer pleasure of delving into a new book and being entertained or enlightened by the thoughts and words of another, there is also the possibility you may glean some essential truths or wise ideas about your own life. Such is the case with several new books…
Brain Boosters: Different Activities To Keep Your Brain In The Game
March 1, 2023
If you’re an avid (or even casual) agebuzz reader, you know that there are many aspects of your lifestyle and habits that maintain and support your aging brain. Whether it’s eating a healthy diet, partaking in regular physical exercise, keeping socially active, or diving into the latest crossword puzzle, it’s…
Normal Aging: Memory Problems Are Not Always A Sign Of Dementia
January 18, 2023
We’ve all experienced it. Introduced to some new people in a social setting, you feel confused as to who was whom when discussing the gathering later that evening. Or, when asked a question, it takes you longer to retrieve the answer than it previously might have. Or maybe a friend…
Hope In A Bottle: Leqembi, The Newly Approved Alzheimer’s Medication
January 11, 2023
As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…